Whitney M. Laughlin - 15 Jan 2026 Form 4/A - Amendment Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Role
Chief Legal Officer
Signature
/s/ Whitney M. Laughlin
Issuer symbol
AMN
Transactions as of
15 Jan 2026
Net transactions value
-$26,041
Form type
4/A - Amendment
Filing time
30 Jan 2026, 10:51:47 UTC
Date Of Original Report
16 Jan 2026
Previous filing
17 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Laughlin Whitney M Chief Legal Officer 2999 OLYMPUS BOULEVARD, SUITE 500, DALLAS /s/ Whitney M. Laughlin 29 Jan 2026 0001992434

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMN Common Stock Options Exercise $0 +202 +0.99% $0.000000 20,698 15 Jan 2026 Direct F1
transaction AMN Common Stock Tax liability $1,173 -60 -0.29% $19.55 20,638 15 Jan 2026 Direct F2
transaction AMN Common Stock Options Exercise $0 +749 +3.6% $0.000000 21,387 15 Jan 2026 Direct F1
transaction AMN Common Stock Tax liability $4,360 -223 -1% $19.55 21,164 15 Jan 2026 Direct F2
transaction AMN Common Stock Options Exercise $0 +3,537 +17% $0.000000 24,701 15 Jan 2026 Direct F1
transaction AMN Common Stock Tax liability $20,508 -1,049 -4.2% $19.55 23,652 15 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMN Restricted Stock Units Options Exercise $0 -202 -100% $0.000000 0 15 Jan 2026 Common Stock 202 Direct F3, F4, F5
transaction AMN Restricted Stock Units Options Exercise $0 -749 -49% $0.000000 772 15 Jan 2026 Common Stock 749 Direct F3, F5, F6
transaction AMN Restricted Stock Units Options Exercise $0 -3,537 -33% $0.000000 7,182 15 Jan 2026 Common Stock 3,537 Direct F3, F5, F7
transaction AMN Restricted Stock Units Award $0 +19,641 $0.000000 19,641 15 Jan 2026 Common Stock 19,641 Direct F5, F8, F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common stock acquired on the vesting of Restricted Stock Units.
F2 Number of shares withheld for tax purposes.
F3 The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
F4 The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
F5 Restricted Stock Units do not have an expiration date.
F6 The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
F7 The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
F8 The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
F9 The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
F10 Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 19,641 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 19,641 securities were beneficially owned by reporting person, not 39,282 as previously reported.